Industry: Rigid Packaging (Plastics, Glass & Metal) (Packaging)
Source: https://www.mordorintelligence.com/industry-reports/pharmaceutical-plastic-packaging-market
Scraped Date: 2026-09-17
| Market Metric | Details |
|---|---|
| Base Market Size | USD 9.98 billion |
| Projected Forecast (2031) | USD 9.98 billion |
| Growth Rate (CAGR) | 3.92 % |
| Largest Market Region | N/A |
| Fastest-Growing Region | N/A |
!Major players in Pharmaceutical Plastic Packaging industry
!Pharmaceutical Plastic Packaging Market Size
!Pharmaceutical Plastic Packaging Market Share by Raw Material, 2025
!Pharmaceutical Plastic Packaging Market Share by Route of Drug Delivery, 2025
!Pharmaceutical Plastic Packaging Market Growth Rate by Region
!Pharmaceutical Plastic Packaging Market Concentration
!Icon
!Vijeron Intelligence on Facebook
!Vijeron Intelligence on Pinterest
!Vijeron Intelligence on Instagram
!GPTW
Market Overview
Study Period | 2020 - 2031 |
Market Size (2026) | USD 9.98 Billion |
Market Size (2031) | USD 12.09 Billion |
Growth Rate (2026 - 2031) | 3.92 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Market Concentration | Medium |
Major Players*Disclaimer: Major Players sorted in no particular order
Image © Vijeron Intelligence. Reuse requires attribution under CC BY 4.0.
|
Pharmaceutical Plastic Packaging Market Analysis by Vijeron IntelligenceThe pharmaceutical plastic packaging market size is projected to expand from USD 9.57 billion in 2025 and USD 9.98 billion in 2026 to USD 12.09 billion by 2031, registering a 3.92% CAGR between 2026 to 2031. Sustained uptake of biologics and specialty injectables, tightening circular-economy regulations, and the proliferation of home-health therapies continue to shape competitive priorities. Larger buyers increasingly demand tamper-evident, traceable, and recyclable packs that safeguard complex drug chemistries without compromising speed to market. Suppliers are responding by integrating blow-fill-seal, multilayer barrier films, and AI-enabled inline inspection, moves that shorten qualification cycles and reduce scrap. Interlinked regulatory and sustainability mandates are steering investments toward certified recycled resin and bio-based feedstock, while e-commerce distribution keeps fueling lightweight, unit-dose format adoption.
Key Report Takeaways
Global Pharmaceutical Plastic Packaging Market Trends and InsightsDrivers Impact Analysis*
Driver | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
Growing demand for plastic packs for biologics and injectables | +1.2% | Global | Medium term (2-4 years) |
Expansion of generic drug production in emerging markets | +0.8% | Asia-Pacific, South America, Africa | Long term (≥ 4 years) |
Lightweight and shatter-proof logistics advantage | +0.7% | Global | Short term (≤ 2 years) |
Home-health and e-commerce unit-dose adoption | +0.6% | North America, Europe, Asia-Pacific | Medium term (2-4 years) |
AI-enabled predictive maintenance for BFS sterility | +0.4% | North America, Europe | Short term (≤ 2 years) |
Circularity mandates and pharmaceutical-grade PCR supply | +0.3% | Europe, North America, Asia-Pacific | Long term (≥ 4 years) |
Source: Vijeron Intelligence |
Competitive Landscape
The top five suppliers, Amcor, Gerresheimer, AptarGroup, West Pharmaceutical Services, and Berry Global, collectively represent well over half of installed capacity, underscoring moderate consolidation. Recent shifts emphasize capacity localization: Gerresheimer’s USD 120 million Indian syringe plant brings production within one-day trucking of major vaccine hubs, slashing lead times for domestic demand. Amcor’s Brazilian acquisition adds flexible and rigid assets, reinforcing its one-stop offering for biologics across South America.
Innovation pipelines reveal strategic pivots toward smart and circular designs. West’s 2025 launch of an RFID-enabled self-injection system combines tamper evidence and adherence data capture, and AptarGroup’s barrier-enhanced nasal systems cater to preservative-free formulations demanded by European allergen therapy specialists. Berry Global’s investment in United States HDPE clean-room molding extends supply redundancy for high-potency applications. Patent analytics show a surge in low-extractable cyclic olefin structures and micro-taggant anticounterfeit coatings filed during 2025-2026.
Competitive heat intensifies as Asia-Pacific challengers harness cost advantage and government subsidies to supply CDMOs serving Western drug sponsors. Digital manufacturing techniques—computer vision for defect mapping, automated tool-change robots, and cloud MES integration—compress lead times and allow rapid iteration on geometry. Sustainability credentials increasingly influence procurement scoring, and converters with closed-loop PET or HDPE partnerships secure multiyear offtake agreements from Big Pharma sustainability councils. Despite margin pressures from raw-material price swings, established incumbents retain leverage through GMP pedigree, multi-regional audit readiness, and broad SKU portfolios.
Pharmaceutical Plastic Packaging Industry Leaders* Aptar Group Inc.
Image © Vijeron Intelligence. Reuse requires attribution under CC BY 4.0.
Global Pharmaceutical Plastic Packaging Market Report ScopePharmaceutical plastic packaging involves using plastic materials to package pharmaceutical drugs. Pharmaceutical plastic bottles, tailored for storing and distributing pharmaceutical products, are pivotal in upholding the safety, efficacy, and integrity of medications and pharmaceutical items. Pharmaceutical plastic packaging products are designed to protect the contents from contamination, moisture, and light, ensuring the drugs remain effective throughout their shelf life. Additionally, plastic packaging offers lightweight, durability, and cost-effectiveness benefits, making it a preferred choice in the pharmaceutical industry.
The Pharmaceutical Plastic Packaging Market Report is segmented by Raw Material (Polypropylene, Polyethylene Terephthalate, High-Density Polyethylene, Low-Density Polyethylene, Cyclic Olefin Polymer/Copolymer, Bio-Based and Recycled Plastics), Product Type (Bottles and Solid Containers, Vials and Ampoules, Pre-Fillable Syringes and Cartridges, Blister Packs and Strip Packs, Pouches/Stick Packs/Sachets, Closures, Caps and Lids, IV Bags and Flexible Bags), Packaging Format (Rigid, Flexible), Route of Drug Delivery (Oral, Parenteral/Injectable, Ophthalmic/Nasal, Topical/Transdermal), End-User (Pharma Manufacturers, CDMOs, Hospitals and Clinics, Home-Care Settings), and Geography (North America, Europe, Asia-Pacific, Middle East, Africa, South America). The Market Forecasts are Provided in Terms of Value (USD).
By Raw MaterialPolypropylene (PP) |
Polyethylene Terephthalate (PET) |
High-Density Polyethylene (HDPE) |
Low-Density Polyethylene (LDPE) |
Cyclic Olefin Polymer / Copolymer (COP/COC) |
Bio-Based and Recycled Plastics |
By GeographyNorth America | United States |
| Canada |
|---|
| Mexico |
Europe | Germany |
| United Kingdom |
|---|
| France |
| Italy |
| Spain |
| Russia |
| Rest of Europe |
Asia-Pacific | China |
| India |
|---|
| Japan |
| South Korea |
| Australia and New Zealand |
| Rest of Asia-Pacific |
Middle East | United Arab Emirates |
| Saudi Arabia |
|---|
| Turkey |
| Rest of Middle East |
Africa | South Africa |
| Nigeria |
|---|
| Egypt |
| Rest of Africa |
South America | Brazil |
| Argentina |
|---|
| Rest of South America |
It is projected to reach USD 12.09 billion by 2031, based on a 3.92% CAGR from 2026 to 2031.
Polyethylene terephthalate held 34.23% of 2025 demand, topping all other resins.
Flexible packs are expected to grow at a 4.31% CAGR, outpacing rigid alternatives.
Self-administration trends and biologic therapies are driving a 5.27% CAGR for prefillable syringes and cartridges.
Asia-Pacific is forecast to post a 4.91% CAGR because of manufacturing expansion in China and India.
EU SUP, EPR fees, and FDA guidance push converters toward recyclable monomaterial packs and certified recycled resin to balance compliance and sustainability.